Company Filing History:
Years Active: 2001-2005
Title: Vincent James LaPosta: Innovator in Vaccine Development
Introduction
Vincent James LaPosta is a notable inventor based in Pittsford, NY (US). He has made significant contributions to the field of vaccine development, holding a total of 4 patents. His work focuses on enhancing the immune response to various antigens, particularly in the context of meningococcal and pneumococcal vaccines.
Latest Patents
LaPosta's latest patents include innovative formulations for meningococcal vaccines that incorporate interleukin-12. This invention involves vaccine compositions that consist of a mixture of antigens, such as pneumococcal or meningococcal antigens, and interleukin IL-12, which may be adsorbed onto a mineral in suspension. The pneumococcal or meningococcal antigens can be conjugated to a carrier molecule, thereby modulating the protective immune response to the antigen. Similarly, his pneumococcal vaccines formulated with interleukin-12 follow the same principles, aiming to enhance the immune response through advanced vaccine compositions.
Career Highlights
Throughout his career, LaPosta has worked with prominent companies in the pharmaceutical industry, including Wyeth Holdings Corporation and American Cyanamid Company. His experience in these organizations has contributed to his expertise in vaccine development and innovation.
Collaborations
One of his notable collaborators is John Hayward Eldridge, with whom he has worked on various projects related to vaccine formulations and immunology.
Conclusion
Vincent James LaPosta's contributions to vaccine development through his innovative patents and collaborations highlight his significant role in advancing medical science. His work continues to impact the field positively, paving the way for improved vaccine efficacy and public health.